Print FriendlySIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 149,416.26 |
| Enterprise Value ($M) | 143,866.26 |
| Book Value ($M) | 10,124.00 |
| Book Value / Share | 24.97 |
| Price / Book | 14.76 |
| NCAV ($M) | 2,626.00 |
| NCAV / Share | 6.48 |
| Price / NCAV | 56.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.66 |
| Return on Assets (ROA) | 1.52 |
| Return on Equity (ROE) | 2.56 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.25 |
| Current Ratio | 1.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 13,425.00 |
| Assets | 20,923.00 |
| Liabilities | 10,799.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock Inc. | 4.80 | -5.30 | |
| 13G/A | Baillie Gifford & Co | 11.18 | 83.82 | |
| 13G/A | Flagship Ventures Fund IV General Partner LLC | 8.40 | -35.02 | |
| 13G/A | Bancel Stephane | 7.09 | -9.30 | |
| 13G/A | Astrazeneca Plc | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 5.91 | 34.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 8,853,529 | 29,419,027 | 30.09 | |
| 6,485,468 | 33,457,742 | 19.38 | |
| 632,803 | 4,076,690 | 15.52 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MORF – Morphic Holding Inc | MREO – Mereo BioPharma Group plc |
| MRKR – Marker Therapeutics Inc | MRNS – Marinus Pharmaceuticals Inc |
| MRSN – Mersana Therapeutics Inc |
Financial data and stock pages provided by
Fintel.io
